RT Journal Article SR Electronic T1 BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment JF Thorax JO Thorax FD BMJ Publishing Group Ltd and British Thoracic Society SP 800 OP 805 DO 10.1136/thx.2005.046797 VO 60 IS 10 YR 2005 UL http://thorax.bmj.com/content/60/10/800.abstract AB Guidelines have been compiled by The Joint Tuberculosis Committee of the British Thoracic Society to quantify the risks of reactivation of tuberculosis with anti-tumour necrosis factor α (anti-TNF-α) treatment. These guidelines are intended to inform respiratory physicians, gastroenterologists, rheumatologists and dermatologists, together with specialist nurses in those disciplines.